CD274 and cancer: KEGG pathway enrichment analysis revealed that the RMSGs were mainly involved in immune and inflammatory pathways, including PD-L1 expression and the tPD-1 checkpoint pathway in cancer, the T-cell receptor signaling pathway, NK cell-mediated cytotoxicity, cytokine–cytokine receptor interaction, and the chemokine signaling pathway (Figure 5A).